Healthcare stocks see mixed performance as Dr Lal Pathlabs and Aurobindo Pharma rise over 2% after CLSA upgrades their ratings to 'outperform.' Dr Reddy's Laboratories falls 1% after a downgrade to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback